ClinicalTrials.gg
CompletedNCT04771221LPRUpdated Jan 10, 2023

Method of Early Diagnosis of Laryngopharyngeal Reflux

An interventional study of pH metry and Filling out the questionnaire in Laryngopharyngeal Reflux, Laryngopharyngitis Chronic and Gastro Esophageal Reflux, sponsored by Kazakh Medical University of Continuing Education. Completed at 2 sites in Kazakhstan. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-01-10.

Sponsored by Kazakh Medical University of Continuing Education · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
385
Allocation
Non-randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The investigator will issue a Patient Information Consent for the participant in the study. 1.Patients will be asked to complete the Reflux Symptom Index questionnaire.

Clinical survey, medical history. 2. Objective methods for assessing the patient's condition:

  • examination of ENT organs. 3. Laboratory and instrumental research methods: Endoscopic laryngoscopy and video laryngoscopy, pH-metry, acoustic voice analysis.

4.Sociological method. 5. Subjective methods for assessing the condition of the larynx. 6. Аnalysis of the received data

Read the detailed description

The investigator will issue a Patient Information Consent for the participant in the study. 1.Patients will be asked to complete the Reflux Symptom Index questionnaire.

Clinical survey, medical history 2. Objective methods for assessing the patient's condition:

  • examination of ENT organs: rhinoscopy, otoscopy, pharyngoscopy and laryngoscopy 3. Laboratory and instrumental research methods - Endoscopic laryngoscopy and video laryngoscopy. pH-metry: The collection of mucus from the laryngopharynx for the determination of acid-base values. Acoustic voice analysis: objective assessment of the voice condition 4.Sociological method: determination of lifestyle, nutrition, the presence or absence of bad habits.
  1. Subjective methods for assessing the condition of the larynx - Questionnaires.
  1. Аnalysis of the received data
02

Conditions studied

  • Laryngopharyngeal Reflux
  • Laryngopharyngitis Chronic
  • Gastro Esophageal Reflux
  • Laryngitis

Keywords

  • Laryngopharyngeal Reflux
  • Laryngopharyngitis Chronic
  • Gastro Esophageal Reflux
  • Laryngitis
  • pH monitoring
  • pH metric
  • acoustic voice analysis
03

In context

Laryngopharyngeal Reflux

56 studies on the registry are indexed under Laryngopharyngeal Reflux; 8 are open to participants now.

This study's enrollment of 385 is above the median of 72 across 41 interventional studies indexed under Laryngopharyngeal Reflux.

Browse Laryngopharyngeal Reflux studies →

Lead sponsor

Kazakh Medical University of Continuing Education is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient's
  • Age: 18-75 years old
  • No serious somatic diseases.
  • Patients with complaints of sore throat, coughing, burning sensation in the throat, coughing, frequent sore throat, difficulty swallowing, lump in the throat, foreign body feeling in the throat, voice changes, heartburn and belching.
  • Diagnosis: Chronic pharyngitis
  • Chronic laryngitis

Exclusion criteria

Exclusion Criteria:

  • Disagreement to participate in scientific research
  • Age: under 18 and over 76
  • Severe somatic diseases, organic lesions of the gastrointestinal tract and ENT organs
  • Patients with pulmonary pathologies
  • Patients with allergic manifestations (seasonal hay fever, asthma, etc.)
  • With diagnoses: Acute respiratory diseases
  • Patients with general neuralgic disorders
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
385 participants (actual)

Study arms

  • Experimental
    Main group

    Patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching.

    Diagnostic Test: pH metry · Diagnostic Test: Filling out the questionnaire · Device: Endoscopic laryngoscopy · Device: Acoustic voice analysis

  • Experimental
    Control group 1

    Patients with an early diagnosis of Gastroesophageal reflux disease

    Diagnostic Test: pH metry · Diagnostic Test: Filling out the questionnaire · Device: Endoscopic laryngoscopy

  • Experimental
    Control group 2

    Patients without complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching.

    Diagnostic Test: pH metry · Diagnostic Test: Filling out the questionnaire · Device: Endoscopic laryngoscopy

Interventions

  • Diagnostic testpH metry

    The collection of mucus from the laryngopharynx to determine the acid-base values through pH-metry.

  • Diagnostic testFilling out the questionnaire

    Completion of the questionnaire index of reflux symptoms. An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out. Evaluation results range from 0 to 5, where 0 is an indicator of no problem, and 5 is an indicator of a serious problem

  • DeviceEndoscopic laryngoscopy

    Video laryngoscopy and assessment of the presence / severity of the symptoms. Evaluation results range from 0 to 4, where 0 is an indicator of no problem, and 4 is an indicator of a serious problem

  • DeviceAcoustic voice analysis

    acoustic analysis of the voice was performed in singers with voice disorders before and after treatment using program of the Lingwaves

06

What researchers measure

Primary outcomes

  1. Acidity level of the main group, Week 0

    The acidity level of the larynx is assessed using litmus paper. The range of acidity levels is from 4.5 to 9.0, where below 6.5 indicates the acidity of the environment, above 7.5 - alkalinity.

    Time frame: at the inclusion to the study

  2. Acidity level of the control group 1, Week 0

    The acidity level of the larynx is assessed using litmus paper. The range of acidity levels is from 4.5 to 9.0, where below 6.5 indicates the acidity of the environment, above 7.5 - alkalinity.

    Time frame: at the inclusion to the study

  3. Acidity level of the control group 2, Week 0

    The acidity level of the larynx is assessed using litmus paper. The range of acidity levels is from 4.5 to 9.0, where below 6.5 indicates the acidity of the environment, above 7.5 - alkalinity.

    Time frame: at the inclusion to the study

  4. "Index of reflux symptoms" of the main group, Week 0

    Patients will be asked to complete the Reflux Symptom Index questionnaire. An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out. The severity of the problem is calculated as the summation of all points. The problem is absent if the summation of points is 0. The problem is serious if the summation of points is 5.

    Time frame: at the inclusion to the study

  5. "Index of reflux symptoms" of the control group 1, Week 0

    Patients will be asked to complete the Reflux Symptom Index questionnaire. An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out. The severity of the problem is calculated as the summation of all points. The problem is absent if the summation of points is 0. The problem is serious if the summation of points is 5.

    Time frame: at the inclusion to the study

  6. "Index of reflux symptoms" of the control group 2, Week 0

    Patients will be asked to complete the Reflux Symptom Index questionnaire. An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out. The severity of the problem is calculated as the summation of all points. The problem is absent if the summation of points is 0. The problem is serious if the summation of points is 5.

    Time frame: at the inclusion to the study

  7. Endoscopic laryngoscopy of the main group, Week 0

    Assessment of the state of the larynx on the scale of reflux symptoms. Where the presence and severity of the sign is assessed in points from 0 to 4. Where 0 is an indicator of no problem, and 4 is an indicator of a serious problem.

    Time frame: at the inclusion to the study

  8. Endoscopic laryngoscopy of the control group 1, Week 0

    Assessment of the state of the larynx on the scale of reflux symptoms. Where the presence and severity of the sign is assessed in points from 0 to 4. Where 0 is an indicator of no problem, and 4 is an indicator of a serious problem.

    Time frame: at the inclusion to the study

  9. Endoscopic laryngoscopy of the control group 2, Week 0

    Assessment of the state of the larynx on the scale of reflux symptoms. Where the presence and severity of the sign is assessed in points from 0 to 4. Where 0 is an indicator of no problem, and 4 is an indicator of a serious problem.

    Time frame: at the inclusion to the study

  10. Acoustic voice analysis of the main group, Week 0

    Acoustic analysis of the voice was performed in patients with a voice profession who had a voice disorder using computer program of the Lingwaves.

    Time frame: at the inclusion to the study

Secondary outcomes

  1. Acidity level of the main group, Week 4

    The acidity level of the larynx is assessed using litmus paper. The range of acidity levels is from 4.5 to 9.0, where above 7.5 indicates the alkalinity of the medium, below 6.5 - acidic.

    Time frame: at 4 weeks after initial treatment

  2. Acidity level of the control group 1, Week 4

    The acidity level of the larynx is assessed using litmus paper. The range of acidity levels is from 4.5 to 9.0, where above 7.5 indicates the alkalinity of the medium, below 6.5 - acidic.

    Time frame: at 4 weeks after initial treatment

  3. Acidity level of the control group 2, Week 4

    The acidity level of the larynx is assessed using litmus paper. The range of acidity levels is from 4.5 to 9.0, where above 7.5 indicates the alkalinity of the medium, below 6.5 - acidic.

    Time frame: at 4 weeks after initial treatment

  4. "Index of reflux symptoms" of the main group, Week 4

    Patients will be asked to complete the Reflux Symptom Index questionnaire. An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out. The severity of the problem is calculated as the summation of all points. The problem is absent if the summation of points is 0. The problem is serious if the summation of points is 5.

    Time frame: at 4 weeks after initial treatment

  5. "Index of reflux symptoms" of the control group 1, Week 4

    Patients will be asked to complete the Reflux Symptom Index questionnaire. An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out. The severity of the problem is calculated as the summation of all points. The problem is absent if the summation of points is 0. The problem is serious if the summation of points is 5.

    Time frame: at 4 weeks after initial treatment

  6. "Index of reflux symptoms" of the control group 2, Week 4

    Patients will be asked to complete the Reflux Symptom Index questionnaire. An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out. The severity of the problem is calculated as the summation of all points. The problem is absent if the summation of points is 0. The problem is serious if the summation of points is 5.

    Time frame: at 4 weeks after initial treatment

  7. Endoscopic laryngoscopy of the main group, Week 4

    Assessment of the state of the larynx on the scale of reflux symptoms. Where the presence and severity of the sign is assessed in points from 0 to 4. Where 0 is an indicator of no problem, and 4 is an indicator of a serious problem.

    Time frame: at 4 weeks after initial treatment

  8. Endoscopic laryngoscopy of the control group 1, Week 4

    Assessment of the state of the larynx on the scale of reflux symptoms. Where the presence and severity of the sign is assessed in points from 0 to 4. Where 0 is an indicator of no problem, and 4 is an indicator of a serious problem.

    Time frame: at 4 weeks after initial treatment

  9. Endoscopic laryngoscopy of the control group 2, Week 4

    Assessment of the state of the larynx on the scale of reflux symptoms. Where the presence and severity of the sign is assessed in points from 0 to 4. Where 0 is an indicator of no problem, and 4 is an indicator of a serious problem.

    Time frame: at 4 weeks after initial treatment

  10. Acoustic voice analysis of the main group, Week 4

    Acoustic analysis of the voice was performed in patients with a voice profession who had a voice disorder using computer program of the Lingwaves

    Time frame: at 4 weeks after initial treatment

07

Study locations

2 sites
  • SOS Medical Assistance
    Almaty, Kazakhstan
  • V-ent
    Almaty, Kazakhstan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2021 to primary completion in Feb 2022, 13 months.

Of 14 interventional studies with no phase under Laryngopharyngeal Reflux, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 41. This study's 13 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 23, 2021
First posted
Feb 25, 2021
StartActual
Jan 10, 2021
Primary completionActual
Feb 15, 2022
CompletionActual
Feb 15, 2022
Last update
Jan 10, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 10, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04771221
Lead sponsor
Kazakh Medical University of Continuing Education
Responsible party
Sponsor
First posted
Feb 25, 2021
Start date
Jan 10, 2021
Primary completion
Feb 15, 2022
Completion
Feb 15, 2022
Last update
Jan 10, 2023

Study contacts

Nukusbekova
principal investigator · Doctor

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion